P54756 (EPHA5_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 29, 2013.
Version 143.
History...
Names·Attributes·General annotation·Ontologies·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Ephrin type-A receptor 5 EC=2.7.10.1 Alternative name(s): Brain-specific kinase EPH homology kinase 1 Short name=EHK-1 EPH-like kinase 7 Short name=EK7 Short name=hEK7 | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) [Reference proteome] | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo![]() |
Protein attributes
| Sequence length | 1037 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is further processed into a mature form. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Receptor tyrosine kinase which binds promiscuously GPI-anchored ephrin-A family ligands residing on adjacent cells, leading to contact-dependent bidirectional signaling into neighboring cells. The signaling pathway downstream of the receptor is referred to as forward signaling while the signaling pathway downstream of the ephrin ligand is referred to as reverse signaling. Among GPI-anchored ephrin-A ligands, EFNA5 most probably constitutes the cognate/functional ligand for EPHA5. Functions as an axon guidance molecule during development and may be involved in the development of the retinotectal, entorhino-hippocampal and hippocamposeptal pathways. Together with EFNA5 plays also a role in synaptic plasticity in adult brain through regulation of synaptogenesis. Beside its function in the nervous system, the interaction of EPHA5 with EFNA5 mediates communication between pancreatic islet cells to regulate glucose-stimulated insulin secretion By similarity. |
| Catalytic activity | ATP + a [protein]-L-tyrosine = ADP + a [protein]-L-tyrosine phosphate. |
| Subunit structure | Heterotetramer upon binding of the ligand. The heterotetramer is composed of an ephrin dimer and a receptor dimer. Oligomerization is probably required to induce biological responses By similarity. |
| Subcellular location | Cell membrane By similarity; Single-pass type I membrane protein By similarity. Cell projection › axon By similarity. Cell projection › dendrite Ref.1 Ref.7. |
| Tissue specificity | Almost exclusively expressed in the nervous system in cortical neurons, cerebellar Purkinje cells and pyramidal neurons within the cortex and hippocampus. Display an increasing gradient of expression from the forebrain to hindbrain and spinal cord. Ref.1 Ref.7 |
| Post-translational modification | Phosphorylated. Phosphorylation is stimulated by the ligand EFNA5. Dephosphorylation upon stimulation by glucose, inhibits EPHA5 forward signaling and results in insulin secretion By similarity. Ref.5 |
| Sequence similarities | Belongs to the protein kinase superfamily. Tyr protein kinase family. Ephrin receptor subfamily. Contains 1 Eph LBD (Eph ligand-binding) domain. Contains 2 fibronectin type-III domains. Contains 1 protein kinase domain. Contains 1 SAM (sterile alpha motif) domain. |
Ontologies
Alternative products
| This entry describes 3 isoforms produced by alternative splicing. [Align] [Select] Note: Additional isoforms seem to exist. | ||||||
| Isoform 1 (identifier: P54756-1) This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Isoform 2 (identifier: P54756-2) The sequence of this isoform differs from the canonical sequence as follows: 597-619: SCCECGCGRASSLCAVAHPSLIW → R | ||||||
| Isoform 3 (identifier: P54756-3) The sequence of this isoform differs from the canonical sequence as follows: 1-69: Missing. 563-563: F → SV |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | |||||||||||||||||||||||||||||||||||||||||||||||
Molecule processing | ||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Signal peptide | 1 – 24 | 24 | Potential | |||||||||||||||||||||||||||||||||||||||||||||||||
| Chain | 25 – 1037 | 1013 | Ephrin type-A receptor 5 | PRO_0000016812 | ||||||||||||||||||||||||||||||||||||||||||||||||
Regions | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Topological domain | 25 – 573 | 549 | Extracellular Potential | |||||||||||||||||||||||||||||||||||||||||||||||||
| Transmembrane | 574 – 594 | 21 | Helical; Potential | |||||||||||||||||||||||||||||||||||||||||||||||||
| Topological domain | 595 – 1037 | 443 | Cytoplasmic Potential | |||||||||||||||||||||||||||||||||||||||||||||||||
| Domain | 60 – 238 | 179 | Eph LBD | |||||||||||||||||||||||||||||||||||||||||||||||||
| Domain | 357 – 459 | 103 | Fibronectin type-III 1 | |||||||||||||||||||||||||||||||||||||||||||||||||
| Domain | 469 – 559 | 91 | Fibronectin type-III 2 | |||||||||||||||||||||||||||||||||||||||||||||||||
| Domain | 675 – 936 | 262 | Protein kinase | |||||||||||||||||||||||||||||||||||||||||||||||||
| Domain | 965 – 1029 | 65 | SAM | |||||||||||||||||||||||||||||||||||||||||||||||||
| Nucleotide binding | 681 – 689 | 9 | ATP By similarity | |||||||||||||||||||||||||||||||||||||||||||||||||
| Motif | 1035 – 1037 | 3 | PDZ-binding Potential | |||||||||||||||||||||||||||||||||||||||||||||||||
| Compositional bias | 220 – 354 | 135 | Cys-rich | |||||||||||||||||||||||||||||||||||||||||||||||||
Sites | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Active site | 800 | 1 | Proton acceptor By similarity | |||||||||||||||||||||||||||||||||||||||||||||||||
| Binding site | 707 | 1 | ATP By similarity | |||||||||||||||||||||||||||||||||||||||||||||||||
Amino acid modifications | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 650 | 1 | Phosphotyrosine; by autocatalysis By similarity | |||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 656 | 1 | Phosphotyrosine; by autocatalysis By similarity | |||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 833 | 1 | Phosphotyrosine; by autocatalysis Potential | |||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 982 | 1 | Phosphotyrosine; by autocatalysis By similarity | |||||||||||||||||||||||||||||||||||||||||||||||||
| Glycosylation | 264 | 1 | N-linked (GlcNAc...) Potential | |||||||||||||||||||||||||||||||||||||||||||||||||
| Glycosylation | 299 | 1 | N-linked (GlcNAc...) Potential | |||||||||||||||||||||||||||||||||||||||||||||||||
| Glycosylation | 369 | 1 | N-linked (GlcNAc...) Potential | |||||||||||||||||||||||||||||||||||||||||||||||||
| Glycosylation | 423 | 1 | N-linked (GlcNAc...) Potential | |||||||||||||||||||||||||||||||||||||||||||||||||
| Glycosylation | 436 | 1 | N-linked (GlcNAc...) Potential | |||||||||||||||||||||||||||||||||||||||||||||||||
| Glycosylation | 461 | 1 | N-linked (GlcNAc...) Potential | |||||||||||||||||||||||||||||||||||||||||||||||||
Natural variations | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Alternative sequence | 1 – 69 | 69 | Missing in isoform 3. | VSP_039118 | ||||||||||||||||||||||||||||||||||||||||||||||||
| Alternative sequence | 563 | 1 | F → SV in isoform 3. | VSP_039119 | ||||||||||||||||||||||||||||||||||||||||||||||||
| Alternative sequence | 597 – 619 | 23 | SCCEC…PSLIW → R in isoform 2. | VSP_002999 | ||||||||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 81 | 1 | N → T. Ref.8 Corresponds to variant rs33932471 [ dbSNP | Ensembl ]. | VAR_042138 | ||||||||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 235 | 1 | S → A. Ref.8 Corresponds to variant rs55710198 [ dbSNP | Ensembl ]. | VAR_042139 | ||||||||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 330 | 1 | E → Q. Ref.8 Corresponds to variant rs56205382 [ dbSNP | Ensembl ]. | VAR_042140 | ||||||||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 417 | 1 | R → Q in a lung adenocarcinoma sample; somatic mutation. Ref.8 | VAR_042141 | ||||||||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 503 | 1 | E → K in a lung large cell carcinoma sample; somatic mutation. Ref.8 | VAR_042142 | ||||||||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 506 | 1 | Y → C. Ref.8 Corresponds to variant rs56074660 [ dbSNP | Ensembl ]. | VAR_045912 | ||||||||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 582 | 1 | G → E in a lung adenocarcinoma sample; somatic mutation. Ref.8 | VAR_042143 | ||||||||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 672 | 1 | A → T. Ref.8 Corresponds to variant rs36050417 [ dbSNP | Ensembl ]. | VAR_042144 | ||||||||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 673 | 1 | S → T. Ref.8 Corresponds to variant rs56359290 [ dbSNP | Ensembl ]. | VAR_042145 | ||||||||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 856 | 1 | T → I in a lung squamous cell carcinoma sample; somatic mutation. Ref.8 | VAR_042146 | ||||||||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 959 | 1 | H → R. Ref.8 Corresponds to variant rs56312931 [ dbSNP | Ensembl ]. | VAR_042147 | ||||||||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 1032 | 1 | N → S in a lung large cell carcinoma sample; somatic mutation. Ref.8 | VAR_042148 | ||||||||||||||||||||||||||||||||||||||||||||||||
Experimental info | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 11 | 1 | R → H in CAA64700. Ref.1 | |||||||||||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 87 | 1 | G → D in CAD97914. Ref.3 | |||||||||||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 506 | 1 | Y → H in CAA64700. Ref.1 | |||||||||||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 611 | 1 | A → V in CAD97914. Ref.3 | |||||||||||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 616 | 1 | S → I in CAA64700. Ref.1 | |||||||||||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 820 | 1 | G → E in CAD97914. Ref.3 | |||||||||||||||||||||||||||||||||||||||||||||||||
Secondary structure | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Helix Strand Turn | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 663 – 665 | 3 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 672 – 674 | 3 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 675 – 683 | 9 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 685 – 694 | 10 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 702 – 708 | 7 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 715 – 728 | 14 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 739 – 743 | 5 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 745 – 748 | 4 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 750 – 754 | 5 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 761 – 766 | 6 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Turn | 767 – 770 | 4 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 774 – 793 | 20 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 803 – 805 | 3 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 806 – 808 | 3 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 814 – 816 | 3 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 842 – 844 | 3 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 847 – 852 | 6 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 857 – 873 | 17 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Turn | 878 – 881 | 4 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 884 – 893 | 10 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 905 – 914 | 10 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 919 – 921 | 3 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 925 – 936 | 12 | ||||||||||||||||||||||||||||||||||||||||||||||||||
Sequences
| ||||||||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Extensive splice variation and localization of the EHK-1 receptor tyrosine kinase in adult human brain and glial tumors." Miescher G.C., Taylor V., Olivieri G., Mindermann T., Shrock E., Steck A.J. Brain Res. Mol. Brain Res. 46:17-24(1997) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), SUBCELLULAR LOCATION, TISSUE SPECIFICITY. Tissue: Brain. |
| [2] | "Generation and annotation of the DNA sequences of human chromosomes 2 and 4." Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H., Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M., Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Kremitzki C., Oddy L., Du H. Wilson R.K.Nature 434:724-731(2005) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [3] | "The full-ORF clone resource of the German cDNA consortium." Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U., Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A., Wiemann S., Schupp I. BMC Genomics 8:399-399(2007) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3). Tissue: Retina. |
| [4] | "cDNA cloning and tissue distribution of five human EPH-like receptor protein-tyrosine kinases." Fox G.M., Holst P.L., Chute H.T., Lindberg R.A., Janssen A.M., Basu R., Welcher A.A. Oncogene 10:897-905(1995) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 25-1037. Tissue: Brain. |
| [5] | "Cloning of AL-1, a ligand for an Eph-related tyrosine kinase receptor involved in axon bundle formation." Winslow J.W., Moran P., Valverde J., Shih A., Yuan J.Q., Wong S.C., Tsai S.P., Goddard A., Henzel W.J., Hefti F., Beck K.D., Caras I.W. Neuron 14:973-981(1995) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION OF EFNA5 AS LIGAND, PHOSPHORYLATION. |
| [6] | "Unified nomenclature for Eph family receptors and their ligands, the ephrins." Eph nomenclature committee Cell 90:403-404(1997) [PubMed] [Europe PMC] [Abstract] Cited for: NOMENCLATURE. |
| [7] | "Immunohistochemical localization of EphA5 in the adult human central nervous system." Olivieri G., Miescher G.C. J. Histochem. Cytochem. 47:855-861(1999) [PubMed] [Europe PMC] [Abstract] Cited for: SUBCELLULAR LOCATION, TISSUE SPECIFICITY. |
| [8] | "Patterns of somatic mutation in human cancer genomes." Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S., O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S., Bhamra G., Buck G. Stratton M.R.Nature 446:153-158(2007) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS [LARGE SCALE ANALYSIS] THR-81; ALA-235; GLN-330; GLN-417; LYS-503; CYS-506; GLU-582; THR-672; THR-673; ILE-856; ARG-959 AND SER-1032. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EMBL GenBank DDBJ | X95425 mRNA. Translation: CAA64700.1. AC018683 Genomic DNA. No translation available. AC104137 Genomic DNA. No translation available. AC105923 Genomic DNA. No translation available. AC115223 Genomic DNA. No translation available. BX537946 mRNA. Translation: CAD97914.1. L36644 mRNA. Translation: AAA74245.1. | ||||||||||||
| IPI | IPI00008290. IPI00215945. IPI00964566. | ||||||||||||
| RefSeq | NP_004430.4. NM_004439.5. NP_872272.2. NM_182472.2. | ||||||||||||
| UniGene | Hs.654492. | ||||||||||||
3D structure databases | |||||||||||||
| PDBe RCSB PDB PDBj |
| ||||||||||||
| ProteinModelPortal | P54756. | ||||||||||||
| ModBase | Search... | ||||||||||||
Protein-protein interaction databases | |||||||||||||
| MINT | MINT-4722838. | ||||||||||||
| STRING | 9606.ENSP00000273854. | ||||||||||||
PTM databases | |||||||||||||
| PhosphoSite | P54756. | ||||||||||||
Polymorphism databases | |||||||||||||
| DMDM | 259016353. | ||||||||||||
Proteomic databases | |||||||||||||
| PaxDb | P54756. | ||||||||||||
| PRIDE | P54756. | ||||||||||||
Protocols and materials databases | |||||||||||||
| StructuralBiologyKnowledgebase | Search... | ||||||||||||
Genome annotation databases | |||||||||||||
| Ensembl | ENST00000273854; ENSP00000273854; ENSG00000145242. ENST00000354839; ENSP00000346899; ENSG00000145242. | ||||||||||||
| GeneID | 2044. | ||||||||||||
| KEGG | hsa:2044. | ||||||||||||
| UCSC | uc003hcx.3. human. uc003hcy.3. human. uc003hcz.3. human. | ||||||||||||
Organism-specific databases | |||||||||||||
| CTD | 2044. | ||||||||||||
| GeneCards | GC04M066193. | ||||||||||||
| HGNC | HGNC:3389. EPHA5. | ||||||||||||
| MIM | 600004. gene. | ||||||||||||
| neXtProt | NX_P54756. | ||||||||||||
| PharmGKB | PA27821. | ||||||||||||
| GenAtlas | Search... | ||||||||||||
Phylogenomic databases | |||||||||||||
| eggNOG | COG0515. | ||||||||||||
| HOVERGEN | HBG062180. | ||||||||||||
| InParanoid | P54756. | ||||||||||||
| KO | K05106. | ||||||||||||
| OMA | FHNGHIK. | ||||||||||||
| OrthoDB | EOG4894KT. | ||||||||||||
| PhylomeDB | P54756. | ||||||||||||
Enzyme and pathway databases | |||||||||||||
| BRENDA | 2.7.10.1. 2681. | ||||||||||||
| Pathway_Interaction_DB | epha_fwdpathway. EPHA forward signaling. ephrinarevpathway. Ephrin A reverse signaling. ephrina_ephapathway. EphrinA-EPHA pathway. | ||||||||||||
| SignaLink | P54756. | ||||||||||||
Gene expression databases | |||||||||||||
| ArrayExpress | P54756. | ||||||||||||
| Bgee | P54756. | ||||||||||||
| CleanEx | HS_EPHA5. | ||||||||||||
| Genevestigator | P54756. | ||||||||||||
| GermOnline | ENSG00000145242. Homo sapiens. | ||||||||||||
Family and domain databases | |||||||||||||
| Gene3D | 1.10.150.50. 1 hit. 2.60.120.260. 1 hit. 2.60.40.10. 2 hits. | ||||||||||||
| InterPro | IPR001090. Ephrin_rcpt_lig-bd_dom. IPR003961. Fibronectin_type3. IPR008979. Galactose-bd-like. IPR013783. Ig-like_fold. IPR011009. Kinase-like_dom. IPR000719. Prot_kinase_cat_dom. IPR017441. Protein_kinase_ATP_BS. IPR001660. SAM. IPR013761. SAM/pointed. IPR021129. SAM_type1. IPR001245. Ser-Thr/Tyr_kinase_cat_dom. IPR008266. Tyr_kinase_AS. IPR020635. Tyr_kinase_cat_dom. IPR016257. Tyr_kinase_ephrin_rcpt. IPR001426. Tyr_kinase_rcpt_V_CS. [Graphical view] | ||||||||||||
| Pfam | PF01404. Ephrin_lbd. 1 hit. PF00041. fn3. 2 hits. PF07714. Pkinase_Tyr. 1 hit. PF00536. SAM_1. 1 hit. [Graphical view] | ||||||||||||
| PIRSF | PIRSF000666. TyrPK_ephrin_receptor. 1 hit. | ||||||||||||
| PRINTS | PR00109. TYRKINASE. | ||||||||||||
| SMART | SM00615. EPH_lbd. 1 hit. SM00060. FN3. 2 hits. SM00454. SAM. 1 hit. SM00219. TyrKc. 1 hit. [Graphical view] | ||||||||||||
| SUPFAM | SSF49265. FN_III-like. 2 hits. SSF49785. Gal_bind_like. 1 hit. SSF56112. Kinase_like. 1 hit. SSF47769. SAM_homology. 1 hit. | ||||||||||||
| PROSITE | PS01186. EGF_2. 1 hit. Uncertain. PS51550. EPH_LBD. 1 hit. PS50853. FN3. 2 hits. PS00107. PROTEIN_KINASE_ATP. 1 hit. PS50011. PROTEIN_KINASE_DOM. 1 hit. PS00109. PROTEIN_KINASE_TYR. 1 hit. PS00790. RECEPTOR_TYR_KIN_V_1. 1 hit. PS00791. RECEPTOR_TYR_KIN_V_2. 1 hit. PS50105. SAM_DOMAIN. 1 hit. [Graphical view] | ||||||||||||
| ProtoNet | Search... | ||||||||||||
Other | |||||||||||||
| BindingDB | P54756. | ||||||||||||
| ChEMBL | CHEMBL3987. | ||||||||||||
| ChiTaRS | EPHA5. human. | ||||||||||||
| EvolutionaryTrace | P54756. | ||||||||||||
| GenomeRNAi | 2044. | ||||||||||||
| NextBio | 8305. | ||||||||||||
| SOURCE | Search... | ||||||||||||
Entry information
| Entry name | EPHA5_HUMAN | ||||||||
| Accession | Primary (citable) accession number: P54756 Secondary accession number(s): Q7Z3F2 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human and mouse protein kinases Human and mouse protein kinases: classification and index |
| Human chromosome 4 Human chromosome 4: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| SIMILARITY comments Index of protein domains and families |

Clusters with
